Adamsbrown Wealth Consultants LLC Pfizer Inc Transaction History

Adamsbrown Wealth Consultants LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 24, 2023	SELL	$32.09 - $37.51 $1,732 - $2,025	-54 Reduced 0.73%	7,313 $242,000
Q2 2023 Jul 12, 2023	BUY	$36.12 - $41.79 $2,781 - $3,217	77 Added 1.06%	7,367 $270,000
Q1 2023 May 10, 2023	BUY	$39.39 - $51.28 $11,462 - $14,922	291 Added 4.16%	7,290 $297,000
Q4 2022 Jan 27, 2023	SELL	$41.75 - $54.5 $50,267 - $65,618	-1,204 Reduced 14.68%	6,999 $0
Q3 2022 Oct 26, 2022	BUY	$43.76 - $53.42 $32,820 - $40,065	750 Added 10.06%	8,203 $359,000
Q2 2022 Jul 27, 2022	BUY	$46.53 - $55.17 $1,861 - $2,206	40 Added 0.54%	7,453 $391,000
Q1 2022 May 16, 2022	BUY	$45.75 - $56.69 $29,234 - $36,224	639 Added 9.43%	7,413 $384,000
Q4 2021 Feb 17, 2022	BUY	$41.32 - $61.25 $279,901 - $414,907	6,774 New	6,774 $400,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Adamsbrown Wealth Consultants LLC, based on Form 13F filings with the SEC.

Stay updated on Adamsbrown Wealth Consultants LLC with notifications on news.